Literature DB >> 2186771

Has chemotherapy proved itself in head and neck cancer?

J S Tobias1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2186771      PMCID： PMC1971618          DOI： 10.1038/bjc.1990.146

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Adjuvant chemotherapy for head and neck cancer.

Authors:  C Jacobs
Journal:  J Clin Oncol       Date:  1989-07       Impact factor: 44.544

Review 2.  Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer.

Authors:  I F Tannock; G Browman
Journal:  J Clin Oncol       Date:  1986-07       Impact factor: 44.544

3.  A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer.

Authors:  N K Gupta; R C Pointon; P M Wilkinson
Journal:  Clin Radiol       Date:  1987-11       Impact factor: 2.350

Review 4.  Chemotherapy in head and neck cancer.

Authors:  W K Hong; R Bromer
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

5.  Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer.

Authors:  S G Taylor; A K Murthy; D D Caldarelli; J L Showel; K Kiel; K L Griem; B B Mittal; M Kies; J C Hutchinson; L D Holinger
Journal:  J Clin Oncol       Date:  1989-07       Impact factor: 44.544

6.  Carboplatin, an active drug in advanced head and neck cancer.

Authors:  L de Andres Basauri; A Lopez Pousa; E Alba; F Sampedro
Journal:  Cancer Treat Rep       Date:  1986-10

7.  Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.

Authors:  E E Vokes; W J Moran; R Mick; R R Weichselbaum; W R Panje
Journal:  J Clin Oncol       Date:  1989-07       Impact factor: 44.544

8.  The role of chemotherapy in the management of cancer of the head and neck: a review.

Authors:  J R Bertino; B Boston; R L Capizzi
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

9.  Paraplegia in children with malignant teratoma.

Authors:  M E Weinblatt; K Kenigsberg
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860
  9 in total
  7 in total

1.  [Janus-faced character of chemotherapy: a comment on the Abel theses].

Authors:  D Schmähl
Journal:  Klin Wochenschr       Date:  1991-01-04

2.  Improving the poor prognosis of oral squamous cell carcinoma.

Authors:  I Hutchison
Journal:  BMJ       Date:  1994-03-12

3.  Pharmacokinetics and tumor concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer.

Authors:  V C Sileni; V Fosser; P Maggian; E Padula; M Beltrame; M Nicolini; P Arslan
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 4.  Cancer of the head and neck.

Authors:  J S Tobias
Journal:  BMJ       Date:  1994-04-09

5.  Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells?

Authors:  Martin Grimm; Dorothea Alexander; Adelheid Munz; Juergen Hoffmann; Siegmar Reinert
Journal:  Target Oncol       Date:  2013-01-15       Impact factor: 4.493

Review 6.  Current role of chemotherapy in head and neck cancer.

Authors:  J S Tobias
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

Review 7.  Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review.

Authors:  Sandra López-Verdín; Jesús Lavalle-Carrasco; Ramón G Carreón-Burciaga; Nicolás Serafín-Higuera; Nelly Molina-Frechero; Rogelio González-González; Ronell Bologna-Molina
Journal:  Cancers (Basel)       Date:  2018-10-10       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.